Amgen Inc. (AMGN)

218.92
4.80 2.10
NASDAQ : Health Technology
Prev Close 223.72
Open 223.49
Day Low/High 218.70 / 224.28
52 Wk Low/High 170.56 / 244.99
Volume 916.70K
Avg Volume 3.37M
Exchange NASDAQ
Shares Outstanding 588.25M
Market Cap 133.48B
EPS 13.00
P/E Ratio 17.77
Div & Yield 6.40 (2.66%)

Amgen New Sector Perform at RBC

Amgen Builds on a Breakout

Amgen Builds on a Breakout

We would suggest doing some buying here.

How I've Prepared for Hurricane Irma -- and a Market Pullback

How I've Prepared for Hurricane Irma -- and a Market Pullback

As a Miami resident, I've learned the value of hurricane preparation and the 'Jensen Rules'.

How I'm Prepared for Irma -- and a Pullback

How I'm Prepared for Irma -- and a Pullback

As a Florida resident, I've learned the value of preparation and the 'Jensen Rules'.

Illumina Lights the Way for Biotechs

Illumina Lights the Way for Biotechs

Today's breakout move in the stock is a highlight of the surging sector.

Illumina Lights the Way for Biotechs

Illumina Lights the Way for Biotechs

Today's breakout move in the stock is a highlight of the surging sector.

BMO Cuts Amgen to Market Perform

The Dow Binges on Earnings

The Dow Binges on Earnings

Get ready for another heavy earnings slate

Intermediate Trade: QQQ

Intermediate Trade: QQQ

Try this bearishly biased, out-of-the-money put spread on the Nasdaq 100 ETF.

Intermediate Trade: QQQ

Intermediate Trade: QQQ

Consider this bearishly biased, August put spread.

With Solid Base, Amgen Keeps Climbing

With Solid Base, Amgen Keeps Climbing

The stock is set up well for more upside and remains very near a low-risk buy zone.

Intermediate Trade: QQQ

Intermediate Trade: QQQ

The tactic is the bearishly biased, calendar diagonal call spread, which controls the risk of the trade.

Takeaways and Observations

"Success breeds complacency. Complacency breeds failure. Only the paranoid survive." - Andy Grove   Perhaps this qualifies as a potential warning from "Uncle" Bob Farrell's ten lessons of investing.   Frankly, I thought dumping Ford's Fields was idi...

Wake Up Wall Street: Political Upheaval Surrounding President Trump Shows No Sign of Abating

Wake Up Wall Street: Political Upheaval Surrounding President Trump Shows No Sign of Abating

Wake Up Wall Street: Political Upheaval Surrounding President Trump Shows No Sign of Abating

Closing Bell: PayPal Pushes Nasdaq to New Record; Crude Ends at One-Month Low

Closing Bell: PayPal Pushes Nasdaq to New Record; Crude Ends at One-Month Low

Better-than-expected earnings from PayPal drove the Nasdaq to new records, while a slump in crude oil kneecaps any big gains for the rest of the market.

Early-Morning Earnings Extravaganza

It is hard to keep up with the flurry of first-quarter earnings reports hitting the wires this morning. Here are a few that caught my eye today. Biotech stalwarts Amgen and Celgene posted mixed results, while AbbVie seems to have beat both top- and ...

Cramer: Nasdaq 6000 (the Number) vs. Nasdaq 2000 (the Year)

Cramer: Nasdaq 6000 (the Number) vs. Nasdaq 2000 (the Year)

You think the exchange is overvalued? I don't, and here's why.

Jim Cramer on What's Next for Amgen Shares

Jim Cramer on What's Next for Amgen Shares

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer sheds light on what's next for Amgen AMGN shares following its downgrade by Jefferies.

Cramer: 3 Health Care Bill Scenarios, 3 Game Plans

Cramer: 3 Health Care Bill Scenarios, 3 Game Plans

Get your plan in place, but understand that the Republic is not in jeopardy.

These 4 Healthcare Charts Are Signaling Buys

These 4 Healthcare Charts Are Signaling Buys

Here's a rundown of four technical setups that are showing solid trading potential.

Oppenheimer Healthcare Conf.

Finding Bullish and Bearish Market Reversals

Finding Bullish and Bearish Market Reversals

These stocks are showing signs of changing direction.

Closing Bell: Citi Dumps SeaWorld; U.S. Stocks Churn as Health Care Falls

Closing Bell: Citi Dumps SeaWorld; U.S. Stocks Churn as Health Care Falls

Stocks churn around the flatline to end the week as a selloff in health care counters gains seen elsewhere.

Cramer: Nothing to See in This Market, Move Along

Cramer: Nothing to See in This Market, Move Along

Today's session is reminiscent of a pre-Trump day.

Midday Report: Amgen Leads Health Care Lower; U.S. Stocks Fall

Midday Report: Amgen Leads Health Care Lower; U.S. Stocks Fall

Stocks creep lower on Friday as a selloff in health care extends into its second day, this time led by Amgen shares.

Jim Cramer Discusses Adobe, Amgen, Canada Goose, Costco and Starbucks

Jim Cramer Discusses Adobe, Amgen, Canada Goose, Costco and Starbucks

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer discusses Friday's most talked about stocks including Adobe Systems, Amgen, Canada Goose, Costco and Starbucks.

Jim Cramer: I Don't Want to Give Up On Amgen

Jim Cramer: I Don't Want to Give Up On Amgen

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer doesn't want to give up on Amgen.

Is Amgen's Cholesterol Drug Repatha Worth Its Hefty Price Tag?

Is Amgen's Cholesterol Drug Repatha Worth Its Hefty Price Tag?

Repatha costs $14,000 per year before discounts.

Cramer on What to Expect From Amgen's Investors Day Friday

Cramer on What to Expect From Amgen's Investors Day Friday

'It'll still go higher.'

Cramer: The Airlines and Health-Care Names Are Really Soaring

Cramer: The Airlines and Health-Care Names Are Really Soaring

This reversal has been incredible to watch.